You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股開市》恆指高開13點 藥股造好 比亞迪受壓
美聯儲局主席鮑威爾指美國經濟未到達可縮減買債規模程度,美股昨個別發展,道指及標普指數上升,納指偏軟。恆指今早高開13點或0.05%,報27,801點;國指低開7點或0.07%,報10,057點。恆生科技指數輕微高開2點,報7,670點。

科技股個別走勢,據報阿裏(09988.HK)、騰訊(00700.HK)及京東(09618.HK)等33家互聯網平臺簽署行業反壟斷自律公約,騰訊、京東分別高開1%及1.4%,阿裏高開0.6%。快手(01024.HK)高開1.5%,小米(01810.HK)高開0.6%。美團(03690.HK)則低開1.9%,瑞聲(02018.HK)低開近2%。

匯控(00005.HK)低開1.4%,友邦保險(01299.HK)低開1%。港交所(00388.HK)高開0.6%。中移動(00941.HK)高開0.2%。工行(01398.HK)低開1.1%。比亞迪(01211.HK)再遭喜馬拉雅資本減持套現逾8.1億元,股價低開6.9%。

醫藥股造好,藥明生物(02269.HK)高開5.9%,石藥集團(01093.HK)高開4.9%,中生製藥(01177.HK)亦高開2.4%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account